| pubmed-article:10138923 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10138923 | lifeskim:mentions | umls-concept:C0242510 | lld:lifeskim |
| pubmed-article:10138923 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:10138923 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:10138923 | lifeskim:mentions | umls-concept:C0032893 | lld:lifeskim |
| pubmed-article:10138923 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:10138923 | lifeskim:mentions | umls-concept:C1522240 | lld:lifeskim |
| pubmed-article:10138923 | lifeskim:mentions | umls-concept:C0278329 | lld:lifeskim |
| pubmed-article:10138923 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10138923 | pubmed:dateCreated | 1995-1-23 | lld:pubmed |
| pubmed-article:10138923 | pubmed:abstractText | Influencing prescribing practices and the implementation of pharmaceutical care utilizing the drug use evaluation (DUE) process at a 891-bed teaching hospital are described. The DUE program has been structured to provide for significant pharmacy involvement while maintaining medical staff responsibility as outlined by the Joint Commission on Accreditation of Healthcare Organizations. A multidisciplinary approach is used to identify problems and develop prescribing criteria and educational initiatives. Pharmacists provide drug therapy monitoring and engage in clinical interventions and documentation of outcomes on a daily basis. DUE program pharmacists help target possible interventions, assure monitoring and outcome documentation, and compile results of all initiatives for reporting purposes to the medical staff and quality assessment program. Specific performance compliance and problems are identified and incorporated into the credentialing process. Corrective measures are determined by the Pharmacy and Therapeutics (P&T) Subcommittee with subsequent actions carried out by peer physicians. The net result is a positive influence on prescribing practices that improves the appropriate and effective use of drugs and improves patient outcomes. | lld:pubmed |
| pubmed-article:10138923 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10138923 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10138923 | pubmed:citationSubset | H | lld:pubmed |
| pubmed-article:10138923 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10138923 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10138923 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10138923 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10138923 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10138923 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:10138923 | pubmed:issn | 0271-1206 | lld:pubmed |
| pubmed-article:10138923 | pubmed:author | pubmed-author:MorganD EDE | lld:pubmed |
| pubmed-article:10138923 | pubmed:author | pubmed-author:RossM BMB | lld:pubmed |
| pubmed-article:10138923 | pubmed:author | pubmed-author:MutnickA HAH | lld:pubmed |
| pubmed-article:10138923 | pubmed:author | pubmed-author:SloanN ENE | lld:pubmed |
| pubmed-article:10138923 | pubmed:author | pubmed-author:PeroutkaJ AJA | lld:pubmed |
| pubmed-article:10138923 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10138923 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:10138923 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10138923 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10138923 | pubmed:pagination | 1-12 | lld:pubmed |
| pubmed-article:10138923 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:meshHeading | pubmed-meshheading:10138923... | lld:pubmed |
| pubmed-article:10138923 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:10138923 | pubmed:articleTitle | Influencing prescribing practices and associated outcomes utilizing the drug use evaluation process. | lld:pubmed |
| pubmed-article:10138923 | pubmed:affiliation | University of Iowa Hospitals and Clinics, Iowa City. | lld:pubmed |
| pubmed-article:10138923 | pubmed:publicationType | Journal Article | lld:pubmed |
